Microbiome Movement

Real World Study of Recurrent CDI Therapy Demonstrates Efficacy, Safety (Ferring)

Clinical excitement in microbiome drug development from Microbiotica and MaaT Pharma...

Only one week left until the 𝟵𝒕𝒉 𝑴𝒊𝒄𝒓𝒐𝒃𝒊𝒐𝒎𝒆 𝑴𝒐𝒗𝒆𝒎𝒆𝒏𝒕 𝑫𝒓𝒖𝒈 𝑫𝒆𝒗𝒆𝒍𝒐𝒑𝒎𝒆𝒏𝒕 𝑺𝒖𝒎𝒎𝒊𝒕 returns to 📍 Boston!   Don't miss your chance to join EnteroBiotix, Freya Biosciences & Genome & Company and stay ahead of the curve to robustly prove clinical efficacy as regulator and investor scrutiny necessitates more compelling data than ever before.   It’s also the 𝐢𝐧𝐝𝐮𝐬𝐭𝐫𝐲’𝐬 𝐩𝐫𝐞𝐦𝐢𝐞𝐫 𝐩𝐥𝐚𝐭𝐟𝐨𝐫𝐦 𝐟𝐨𝐫 𝐜𝐨𝐧𝐧𝐞𝐜𝐭𝐢𝐨𝐧-𝐛𝐮𝐢𝐥𝐝𝐢𝐧𝐠 𝐢𝐧 𝟮𝟬𝟮𝟰 – so don’t miss out! 🤝   📣 𝐅𝐈𝐍𝐀𝐋 𝐅𝐄𝐖 𝐏𝐀𝐒𝐒𝐄𝐒 𝐀𝐕𝐀𝐈𝐋𝐀𝐁𝐋𝐄! Grab your spot now before it's too late: https://ter.li/jeaydv

"One of the most exciting opportunities of working in an emerging field is that you're in this pre-competitive space where there's a lot of community and collaboration. We really need one another in this community to become successful, whether it's the manufacturers or the data scientists or any of the service companies needed." says Nikole Kimes, PhD, Founder & Chief Executive Officer at 𝐒𝐢𝐨𝐥𝐭𝐚 𝐓𝐡𝐞𝐫𝐚𝐩𝐞𝐮𝐭𝐢𝐜𝐬. 📣With the 𝟗𝒕𝒉 𝑴𝒊𝒄𝒓𝒐𝒃𝒊𝒐𝒎𝒆 𝑴𝒐𝒗𝒆𝒎𝒆𝒏𝒕 - 𝑫𝒓𝒖𝒈 𝑫𝒆𝒗𝒆𝒍𝒐𝒑𝒎𝒆𝒏𝒕 𝑺𝒖𝒎𝒎𝒊𝒕 kicking off in less than 𝟮 𝐰𝐞𝐞𝐤𝐬, we had the pleasure of speaking with Nikole about the importance of collaboration in the microbial therapeutics industry, the promising areas and biggest hurdles in the microbiome field, and what the industry can learn from recent clinical progress. She also shared her excitement for data sessions at the upcoming summit! 🎉 View the summit details here in detail ➡️ https://ter.li/aohofr The summit is just around the corner! 𝐒𝐞𝐜𝐮𝐫𝐞 𝐲𝐨𝐮𝐫 𝐭𝐢𝐜𝐤𝐞𝐭𝐬 𝐧𝐨𝐰 🎟 to gain the latest insights from industry leaders like Nikole E. Kimes and organizations such as Freya Biosciences, MRM Health, FDA and many more! — don't miss out! Register here ➡️ https://ter.li/wy4u0i

Hoping to Maximize Investment Through Robust Translation, Clinical Data & GMP Manufacturing? … Look no further than the 𝟗𝒕𝒉 𝑴𝒊𝒄𝒓𝒐𝒃𝒊𝒐𝒎𝒆 𝑴𝒐𝒗𝒆𝒎𝒆𝒏𝒕 - 𝑫𝒓𝒖𝒈 𝑫𝒆𝒗𝒆𝒍𝒐𝒑𝒎𝒆𝒏𝒕 𝑺𝒖𝒎𝒎𝒊𝒕! 𝗙𝘂𝗹𝗹 𝗔𝗴𝗲𝗻𝗱𝗮 𝗛𝗲𝗿𝗲➡️ https://ter.li/5bogsn 𝗪𝗲 𝗵𝗮𝘃𝗲 𝟗𝟎+ 𝗔𝘁𝘁𝗲𝗻𝗱𝗲𝗲𝘀 (𝘀𝗼 𝗳𝗮𝗿) 𝗨𝗻𝗶𝘁𝗶𝗻𝗴 𝘁𝗼: 🔬 Discover Platform Innovation: Showcase your research to VCs and thought leaders. 📚 Dive into Fresh R&D: Present your work, get peer feedback, and explore new drug development opportunities. 🏥 The Cutting-Edge from the Clinic: Get updates on clinical progress and future investment. 🌐 Gain Broader Insights: Learn from GI, Neuro, Oncology, Women’s Health, and more. 🤝 Build Your Network: Use our app, join panels, and attend workshops for strategic intelligence and connections. 𝗚𝗿𝗮𝗯 𝗬𝗼𝘂𝗿 𝗖𝗼𝗽𝘆 𝗼𝗳 𝘁𝗵𝗲 𝗙𝘂𝗹𝗹 𝗔𝘁𝘁𝗲𝗻𝗱𝗲𝗲 𝗟𝗶𝘀𝘁➡️ https://ter.li/12adca  With only 𝟐 𝐰𝐞𝐞𝐤𝐬 𝐥𝐞𝐟𝐭 and limited passes remaining, grab yours now to avoid missing out! ➡️ https://ter.li/07ws1y Plus, enjoy 𝗲𝘅𝗰𝗹𝘂𝘀𝗶𝘃𝗲 𝗴𝗿𝗼𝘂𝗽 𝗱𝗶𝘀𝗰𝗼𝘂𝗻𝘁𝘀 to boost collaboration within your team!

View the full details of Ada's talk here: https://ter.li/tm8a5q and join us in Boston from July 10-12! We hope to see you there.

🌟 Unlock Exclusive Savings! 🌟 Don't miss out on our early bird discount for the Microbiome Movement Skin Health and Cosmeceutical Summit. Secure your spot now and save a whopping $1,100! Prices will never be this low again, so act fast and join us to explore the latest advancements in skin health and cosmeceuticals. Learn More: https://ter.li/kbgfhr 📅 Date: September 17-19, 2024 📍 Location: San Diego 🎟️ Register now to take advantage of this limited-time offer and be a part of the leading event in the industry. #MicrobiomeSummit #SkinHealth #Cosmeceuticals #EarlyBirdDiscount #ExclusiveSavings

Microbiome therapies are the next frontier in oncology! 🦠🔬💊 Biomica is thrilled to share positive preliminary results from our ongoing Phase 1 trial of BMC128, our microbiome-based drug, in combination with nivolumab. These findings, which will be showcased at the 2024 American Society of Clinical Oncology (ASCO) annual meeting, show promising trends for treating refractory NSCLC, melanoma, and RCC. The trial highlights the potential of gut microbiota in cancer therapy. While preliminary, these results represent a significant step forward in developing innovative treatments for refractory cancer. Stay tuned for more updates! 📣 Read the full release below: https://lnkd.in/dKFunmJ4 #Biomica #CancerResearch #MicrobiomeTherapeutics #Oncology #ASCO2024 #InnovativeMedicine

💫 Another week of clinical progress across the field of women’s heath 💫 💠 Bayer celebrates successful results from two Phase 3 trials for menopause symptom drugs 💠 May Health raise $25 million to continue clinical progress for non-invasive therapeutic, targeting PCOS-associated infertility 🤝 Collaborating as a community is imperative to continue the revolution of improved market access for diagnostic and therapeutic tools across the globe. From endometriosis to bacterial vaginosis to infertility to pre-term birth to menopause and more, research is gathering pace to improve the quality of lives of millions of women worldwide. 📈 The Women’s Health Therapeutics & Diagnostics Summit is uniquely positioned as the only meeting worldwide uniting senior industry leaders from pharma, biotech and academia, dedicated to propelling the women’s health conversation to the forefront, increasing investment and ultimately clinical progress in 2024. 🎫 And you can confirm your attendance this week with huge savings available ($600). Register before Friday 24th May (midnight) to receive your savings in this exclusive early bird opportunity. Register here - https://ter.li/pyknqn ✨ Join Ferring Pharmaceuticals, Organon, Freya Biosciences, Hera Biotech, Concerto Biosciences, Daré Bioscience, Inc. ,SLBST Pharma and lots more to establish yourself as a core part of the ever-growing women’s health community. ❓ If you have any further questions, please feel free to drop me a message and I would be happy to discuss further. Rashi Taunk Kiran Thomson Nandita Iyer